Cargando…
7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
Background. Ten-day concomitant therapy achieves a high eradication rate in Taiwan. Whether shortening the duration of concomitant therapy can still keep a high eradication rate remains unclear. Aim. To assess the eradication rate of 7-day pantoprazole-containing concomitant therapy in Taiwan and to...
Autores principales: | Kao, Sung-Shuo, Chen, Wen-Chi, Hsu, Ping-I, Lai, Kwok-Hung, Yu, Hsien-Chung, Cheng, Hui-Hwa, Peng, Nan-Jing, Lin, Chiun-Ku, Chan, Hoi-Hung, Tsai, Wei-Lun, Wang, Huay-Min, Tsai, Tzung-Jiun, Lin, Kung-Hung, Tsay, Feng-Woei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408719/ https://www.ncbi.nlm.nih.gov/pubmed/22888337 http://dx.doi.org/10.1155/2012/463985 |
Ejemplares similares
-
A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
por: Tai, Wei-Chen, et al.
Publicado: (2019) -
Gallbladder function predicts subsequent biliary complications in patients with common bile duct stones after endoscopic treatment?
por: Tsai, Tzung-Jiun, et al.
Publicado: (2018) -
Hepatitis B Virus Screening Before Cancer Chemotherapy in Taiwan: A Nationwide Population-Based Study
por: Sun, Wei-Chih, et al.
Publicado: (2021) -
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2015) -
The Compliance of Doctors with Viral Hepatitis B Screening and Antiviral Prophylaxis in Cancer Patients Receiving Cytotoxic Chemotherapy Using a Hospital-Based Screening Reminder System
por: Sun, Wei-Chih, et al.
Publicado: (2015)